Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclosed herewith a copy of the Minutes of the proceedings of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics held its 43rd AGM on August 21, 2025 via video conference with 55 members present. The company did not declare any dividend for FY 2024-25 due to operating losses. Shareholders approved the standalone and consolidated financial statements, re-appointment of Mr. Cedric Lobo (who retires by rotation), and revised Material Related Party Transaction limits with Lensco-The Lens Company for FY 2025-26 upward from Rs. 1.00 Crore to Rs. 12.00 Crores. Members also approved RPTs with GKB Vision Pvt Ltd (Rs. 27 Cr), Lensco (Rs. 15 Cr), and GSV Ophthalmics (Rs. 10 Cr) for FY 2026-27. Ms. Girija Nagvekar was appointed as Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30). Mr. Gaurav Gupta, son of CMD Mr. K.G. Gupta, received a salary hike from USD 6,400 to USD 7,400 per month as CEO of subsidiary Lensco, after sales there grew from USD 319,381 (April 2024) to USD 514,696 (April 2025). Fresh borrowing limit of Rs. 50 Crores was approved under Section 180(1)(c) to fund new lens-making machinery from Bangalore and a Rs. 7.50 Crore term loan.
Skipped dividend signals continued financial pressure, but the sharp sales growth at the US subsidiary and planned capacity expansion point to a turnaround story. Higher RPT limits and Rs. 50 Crore borrowing ceiling indicate the company is gearing up for capex, which shareholders should track closely for execution and return ratios.